Valeri Goutsouliak
Radiation Oncology · Indianapolis, INNPI 1306849880
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.
Across 40 payments — averaging $21.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$183
- Varian Medical Systems, Inc.$108
- AstraZeneca$73
- Clovis Oncology, Inc.$61
- Amgen$48
- Pharmacyclics LLC, An Abbvie Company$44
- plus $339 from 18 others
What the payments were for
- Food & beverage$855100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 2 | $183 |
| Varian Medical Systems, Inc. | 1 | $108 |
| AstraZeneca(2 entities) | 4 | $73 |
| Clovis Oncology, Inc. | 4 | $61 |
| Amgen | 3 | $48 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $44 |
| Astellas Pharma US Inc | 2 | $38 |
| Bayer | 2 | $32 |
| Incyte Corporation | 2 | $27 |
| Tactile Systems Technology Inc | 2 | $26 |
| Novartis | 2 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Novocure Inc. | 1 | $13 |
| Dova Pharmaceuticals | 1 | $13 |
| Merck | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| Kyowa Kirin, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Treatment Planning Systems$108
How this compares
$855 in reported general payments places this provider in the 55th percentile of 116 radiation oncology providers in Indiana.
Other radiation oncology in Indianapolis
- Michael EatonIndianapolis$11K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Peter GarrettIndianapolis$5K
- Garrett JensenIndianapolis$4K
- Alexander YehIndianapolis$3K
- Erin McCammackIndianapolis$2K
- Zachary OaksIndianapolis$2K
- David KimIndianapolis$2K
- Darrel RossIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.